×
Back to Agenda
Day 2: Session 6:
Session Chair(s)
Rajinder Jalali
VP & Head,Medical Affairs & Clinical Research and Global Head Pharmacovigilance, Sun Pharma, India
Speaker(s)
Jayathirtha Gopalakrishna
Principal Sales Consultant, Health Sciences Global Business Unit, Oracle Inc, United States
Day 2: Session 6.1: Machine Learning & Artificial I telligence in PV – A Case Study
David John Lewis, PhD
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance, Novartis Pharma Gmbh, Switzerland
Day 2: Session 6.2: New Approaches to Risk Management & Risk Minimization – Global Strategies
Sibin Kurian
Therapeutic Area Safety Lead, Novartis Pharma AG,, Switzerland
Day 2: Session 6.2: New Approaches to Risk Management & Risk Minimization – Global Strategies
Have an account?